| Feature |
BPC-157 |
TB-500 |
| Full Name |
Body Protection Compound-157 |
Thymosin Beta-4 (fragment) |
| Origin |
Human gastric juice |
Thymus gland protein |
| Primary Mechanism |
Angiogenesis + gut healing |
Cell migration + tissue repair |
| Best For |
Gut, tendons, localized injury |
Systemic healing, muscle, heart |
| Administration |
Oral or subcutaneous injection |
Subcutaneous or IM injection |
| Typical Dose |
250–500 mcg, 1–2x daily |
2–5 mg, 2x/week (loading) |
| FDA Approved |
❌ Research peptide |
❌ Research peptide |
| Stack Together? |
✅ Synergistic |
✅ Synergistic |
Mechanism of Action
BPC-157 — The Gut Healer
BPC-157 (Body Protection Compound-157) is a 15-amino-acid peptide originally isolated from human gastric juice. Its healing mechanisms include:
- Angiogenesis — promotes formation of new blood vessels, accelerating nutrient delivery to damaged tissue
- Nitric oxide modulation — regulates the NO system to support healing and protect against damage
- Growth factor upregulation — increases expression of growth hormone receptors and growth factors (EGF, HGF)
- GI tract protection — protects and heals stomach and intestinal lining, counteracts NSAID damage
- Tendon and ligament repair — accelerates tendon-to-bone healing in animal models
- Neuroprotective effects — evidence of dopaminergic and serotonergic system modulation
TB-500 — The Systemic Repairer
TB-500 is a synthetic peptide based on the active region of thymosin beta-4 (Tβ4), a naturally occurring 43-amino-acid protein. Its mechanisms include:
- Actin regulation — upregulates actin, a cell-building protein critical for cell migration and wound healing
- Cell migration — promotes migration of endothelial cells and keratinocytes to injury sites
- Anti-inflammatory — reduces pro-inflammatory cytokines at injury sites
- Cardiac repair — research shows potential for heart tissue regeneration after myocardial infarction
- Hair growth — stimulates hair follicle stem cells (observed in animal studies)
- Systemic distribution — due to its small molecular size, it circulates widely and reaches distant injury sites
💡 The Key Difference
BPC-157 excels at local, targeted healing — especially in the gut, tendons, and at specific injection sites. TB-500 is a systemic healer that circulates throughout the body, making it ideal for widespread inflammation, multiple injuries, or cardiac/musculoskeletal recovery. This is why they complement each other so well.
Best Use Cases
When BPC-157 May Be Best
- Gut issues — leaky gut, IBS, gastric ulcers, NSAID-induced gut damage
- Tendon/ligament injuries — Achilles tendinopathy, tennis elbow, rotator cuff
- Localized injuries — when you can inject near the injury site
- Post-surgical healing — accelerating recovery at a specific wound site
- Neuroprotection — dopaminergic system support, nerve damage recovery
When TB-500 May Be Best
- Systemic inflammation — multiple injury sites or chronic inflammatory conditions
- Muscle injuries — strains, tears, and chronic muscle damage
- Cardiac recovery — post-cardiac event tissue repair (research context)
- Fibrosis reduction — may help reduce scar tissue formation
- Athletic recovery — general sports injury recovery and performance maintenance
🔄 When to Stack Both
Many practitioners use both simultaneously for complex or multiple injuries. Common stack scenarios:
- Post-surgery with gut issues from painkillers (BPC-157 for gut + TB-500 for surgical site)
- Athletes with multiple nagging injuries
- Chronic conditions with both local and systemic components
- Accelerating recovery timelines when healing is critical
Administration Routes
BPC-157 Administration
- Subcutaneous injection — most common; inject near the injury site for localized effect
- Oral/sublingual — effective for gut-targeted healing; some evidence of systemic absorption
- Intramuscular — less common but used for deep tissue injuries
The oral bioavailability of BPC-157 is notable — it's one of the few peptides that retains activity when taken orally, particularly for GI tract conditions. This makes it uniquely accessible compared to most peptides.
TB-500 Administration
- Subcutaneous injection — most common; doesn't need to be near injury site due to systemic distribution
- Intramuscular injection — alternative route, same systemic effect
- No oral option — TB-500 is not orally bioavailable and must be injected
Dosing Protocols
These are commonly referenced research protocols — not medical recommendations. Always consult a healthcare provider.
| Phase |
BPC-157 |
TB-500 |
| Loading |
250–500 mcg, 2x/day for 2–4 weeks |
2–5 mg, 2x/week for 4–6 weeks |
| Maintenance |
250 mcg, 1x/day |
2 mg, 1x/week |
| Cycle Length |
4–12 weeks typical |
4–8 weeks loading + maintenance |
| Reconstitution |
Bacteriostatic water |
Bacteriostatic water |
| Storage |
Refrigerate after reconstitution |
Refrigerate after reconstitution |
Use our peptide reconstitution calculator to determine exact concentrations when mixing.
Research Status & Evidence Quality
BPC-157 Research
- Animal studies: Extensive — over 100 published studies showing efficacy for GI protection, tendon healing, wound repair, and neuroprotection
- Human trials: Limited — a few small trials for inflammatory bowel disease and wound healing; more are needed
- Safety profile: No significant toxicity observed in animal studies even at high doses; human long-term safety data is lacking
- Regulatory status: Not FDA-approved; classified as a research chemical in the US
TB-500 Research
- Animal studies: Strong evidence for wound healing, cardiac repair, and anti-inflammatory effects; extensively studied in veterinary medicine (equine)
- Human trials: Very limited — thymosin beta-4 has been studied in human cardiac and ophthalmic applications but TB-500 specifically has minimal human data
- Safety profile: Generally well-tolerated in animal studies; theoretical concern about promoting growth of existing tumors (not established)
- Regulatory status: Not FDA-approved; banned by WADA for athletic competition; veterinary use is more established
⚠️ Evidence Caveat
Both peptides have strong animal evidence but limited human clinical trial data. Most dosing protocols are derived from animal studies, anecdotal reports, and practitioner experience rather than randomized controlled trials. The research is promising but not yet at the level of FDA-approved therapies. See our BPC-157 research page and TB-500 research page for detailed study summaries.
⚖️ The Verdict: Which One Should You Choose?
Choose BPC-157 if:
- Your primary concern is gut healing (leaky gut, IBS, ulcers, NSAID damage)
- You have a specific localized injury (tendon, ligament, wound)
- You prefer the option of oral administration over injections
- You want the peptide with the most published research
Choose TB-500 if:
- You have multiple injury sites or systemic inflammation
- Muscle injuries or strains are your primary concern
- You're recovering from a cardiac event (under medical supervision)
- You need systemic healing coverage rather than targeted repair
Stack Both if:
- You have complex injuries with both local and systemic components
- You want to maximize healing potential for serious recovery
- Budget allows — the combination is considered more effective than either alone
- You're post-surgery with gut issues from medications
Bottom Line:
These aren't competing peptides — they're complementary ones. BPC-157 is the specialist (gut and local repair) while TB-500 is the generalist (systemic healing). For most recovery goals, the real question isn't "which one" but "do I need one or both?" Check our interaction checker to verify compatibility with other compounds.
Frequently Asked Questions
What is the difference between BPC-157 and TB-500?
▼
BPC-157 is a gastric peptide that promotes healing primarily through angiogenesis and gut repair. TB-500 is based on thymosin beta-4 and promotes systemic tissue repair through cell migration and differentiation. BPC-157 excels at localized and gut healing, while TB-500 is better for systemic recovery.
Can you stack BPC-157 and TB-500 together?
▼
Yes, they are commonly stacked. They work through complementary mechanisms — BPC-157 promotes angiogenesis and local healing while TB-500 enhances cell migration and systemic repair. Many practitioners report synergistic effects when using both together.
Is BPC-157 better than TB-500 for gut healing?
▼
Yes, BPC-157 is generally considered superior for gut issues. It was originally isolated from human gastric juice and has extensive research showing GI protection and healing. It can also be taken orally for gut-targeted effects, while TB-500 requires injection.
What is the typical dosing protocol for BPC-157 and TB-500?
▼
Common research protocols use BPC-157 at 250–500 mcg once or twice daily and TB-500 at 2–5 mg twice per week during loading, then 2 mg weekly for maintenance. Use our peptide calculator for reconstitution math.
Are BPC-157 and TB-500 FDA approved?
▼
Neither is FDA-approved. They are classified as research peptides with extensive animal data but limited human clinical trials. The FDA has taken enforcement actions against some companies selling these for human use.
Peptide Research Tools
Calculate reconstitution volumes and check interaction safety
⚕️ Disclaimer: This comparison is for educational and research reference only. It does not constitute medical advice. Always consult your healthcare provider. Data cited is from published clinical trials and research literature.